Prevalence of adrenal masses in Japanese patients with type 2 diabetes mellitus

Diabetology and Metabolic Syndrome

Volumn 2, Issue 1, 2010, Pages

  Hiroi, Naoki ^a   Sue, Mariko ^a   Yoshihara, Aya ^a   Ichijo, Takamasa ^a,b   Yoshida Hiroi, Mayumi ^c   Higa, Mariko ^b   Yoshino, Gen ^a  

^a TOHO UNIVERSITY SCHOOL OF MEDICINE   (Japan)

^b SAISEIKAI YOKOHAMASHI TOBU HOSPITAL   (Japan)

^c Kawasaki Social Insurance Hospital   (Japan)

Author keywords

[No Author keywords available]

Indexed keywords

ADRENALIN; ALDOSTERONE; CAPTOPRIL; CORTICOTROPIN; DEXAMETHASONE; FUROSEMIDE; HYDROCORTISONE; NORADRENALIN; PRASTERONE SULFATE;

ADRENAL CORTEX ADENOMA; ADRENAL GLAND; ADRENAL INCIDENTALOMA; ADRENAL TUMOR; ADRENALIN BLOOD LEVEL; ADULT; AGED; ALDOSTERONE BLOOD LEVEL; ARTICLE; COMPUTER ASSISTED TOMOGRAPHY; CORTICOTROPIN BLOOD LEVEL; CUSHING SYNDROME; DIABETIC PATIENT; FEMALE; HORMONE SYNTHESIS; HUMAN; HYDROCORTISONE BLOOD LEVEL; HYPERALDOSTERONISM; JAPAN; JAPANESE; MAJOR CLINICAL STUDY; MALE; NON INSULIN DEPENDENT DIABETES MELLITUS; NORADRENALIN BLOOD LEVEL; PREVALENCE; PRIMARY HYPERALDOSTERONISM; PRIORITY JOURNAL; RETROSPECTIVE STUDY;

EID: 78650271915     PISSN: None     EISSN: 17585996     Source Type: Journal    
DOI: 10.1186/1758-5996-2-71     Document Type: Article

References (39)

1. Adrenal incidentaloma. LM Brunt JF Moley, World J Surg 2001 25 905 13 10.1007/s00268-001-0029-0 11572032
2. Incidentally discovered adrenal masses. RT Kloos MD Gross IR Francis M Korobkin B Shapiro, Endocr Rev 1995 16 460 484 8521790
3. Management of the clinically inapparent adrenal mass (" incidentaloma"). MM Grumbach BM Biller GD Braunstein KK Campbell JA Carney PA Godley EL Harris JK Lee YC Oertel MC Posner JA Schlechte HS Wieand, Ann Intern Med 2003 138 424 429 12614096
4. The Clinically Inapparent Adrenal Mass: Update in Diagnosis and Management. G Mansmann J Lau E Balk M Rothberg Y Miyachi SR Bornstein, Endocr Rev 2004 25 309 40 10.1210/er.2002-0031 15082524
5. The improvement of insulin resistance in patients with adrenal incidentaloma by surgical resection. S Midorikawa H Sanada S Hashimoto T Suzuki T Watanabe, Clin Endocrinol (Oxf) 2001 54 797 804 10.1046/j.1365-2265.2001. 01274.x 11422115
6. Adrenal incidentalomas: a manifestation of the metabolic syndrome? M Reincke M Fassnacht S Väth P Mora B Allolio, Endocr Res 1996 22 757 61 8969938
7. Clinically silent adrenal masses. MD Gross B Shapiro, J Clin Endocrinol Metab 1993 77 885 888 10.1210/jc.77.4.885 8408461
8. Clinical Utility of Noncontrast Computed Tomography Attenuation Value (Hounsfield Units) to Differentiate Adrenal Adenomas/Hyperplasias from Nonadenomas: Cleveland Clinic Experience. AH Hamrahian AG Ioachimescu EM Remer G Motta-Ramirez H Bogabathina HS Levin S Reddy IS Gill A Siperstein EL Bravo, J Clin Endocrinol Metab 2005 90 871 877 10.1210/jc.2004-1627 15572420
9. Adrenal preclinical Cushing's syndrome. H Nawata H Demura T Suda R Takayanagi, Annual report of the Ministry of Health and Welfare 'Disorder of Adrenal Hormones' Research Committee, Japan 1996 223 226 (In Japanese)
10. Prospective study on the prevalence of secondary hypertension among hypertensive patients visiting a general outpatient clinic in Japan. M Omura J Saito K Yamaguchi Y Kakuta T Nishikawa, Hypertens Res 2004 27 193 202 10.1291/hypres.27.193 15080378
11. Prevalence of primary aldosteronism: should we screen for primary aldosteronism before treating hypertensive patients with medication? T Nishikawa J Saito M Omura, Endocr J 2007 54 487 495 10.1507/endocrj.KR-105 17124364
12. A detour guide to the Endocrine Society Clinical Practice Guideline on case detection, diagnosis and treatment of patients with primary aldosteronism. W Arlt, Eur J Endocrinol 2010 162 435 438 10.1530/EJE-09-0869 19797500
13. Fluorescence products of the reaction for the determination of catecholamines with 1,2-diarylethylendiamines. H Nohta MK Lee Y Ohkura, Analytica Chimica Acta 1992 267 137 139 10.1016/0003-2670(92)85015-X
14. Primary adrenal tumours - -a ten-year experience. AP Meagher TB Hugh JH Casey DJ Chisholm JC Farrell M Yeates, Aust N Z J Surg 1988 58 457 462 10.1111/j.1445-2197.1988.tb06235.x 3270316
15. Serendipitous adrenal masses: prevalence, significance, and management. M Abecassis MJ McLoughlin B Langer JE Kudlow, Am J Surg 1985 149 783 788 10.1016/S0002-9610(85)80186-0 4014556
16. On the prevalence of adrenocortical adenomas in an autopsy material in relation to hypertension and diabetes. H Hedeland G Ostberg B Hokfelt, Acta Med Scand 1968 184 211 214 10.1111/j.0954-6820.1968.tb02445.x 5703975
17. Nonfunctioning adrenal masses: incidental discovery on computed tomography. HS Glazer PJ Weyman SS Sagel RG Levitt BL McClennan, AJR Am J Roentgenol 1982 139 81 85 6979870
18. Subclinical hormone secretion by incidentally discovered adrenal masses. RH Caplan PJ Strutt GG Wickus, Arch Surg 1994 129 291 296 8129606
19. Incidental asymptomatic adrenal masses detected by computed tomographic scanning. Is operation required? RA Prinz MH Brooks R Churchill JL Graner AM Lawrence E Paloyan M Sparagana, JAMA 1982 248 701 704 10.1001/jama.248.6.701 7097921
20. Prevalence of adrenal incidentaloma in a contemporary computerized tomography series. S Bovio A Cataldi G Reimondo P Sperone S Novello A Berruti P Borasio C Fava L Dogliotti GV Scagliotti A Angeli M Terzolo, J Endocrinol Invest 2006 29 298 302 16699294
21. Different patterns of steroid secretion in patients with adrenal incidentaloma. M Terzolo G Osella A Al G Borretta GP Magro A Termine P Paccotti A Angeli, J Clin Endocrinol Metab 1996 81 740 744 10.1210/jc.81.2.740 8636297
22. Study of glucose tolerance in consecutive patients harbouring incidental adrenal tumours. JM Fernandez-Real EW Ricart R Sim I Salinas SM Webb, Clin Endocrinol (Oxf) 1998 49 53 61 10.1046/j.1365-2265.1998.00437.x 9797847
23. The size of adrenal incidentalomas correlates with insulin resistance. Is there a cause-effect relationship? G Muscogiuri GP Sorice A Prioletta T Mezza C Cipolla E Salomone A Giaccari A Pontecorvi SD Casa, Clin Endocrinol (Oxf) 2010 21070314
24. Prevalence and natural history of adrenal incidentalomas. L Barzon N Sonino F Fallo G Palu M Boscaro, Eur J Endocrinol 2003 149 4 273 85 10.1530/eje.0.1490273 14514341
25. A survey of adrenal incidentaloma in Japan. H Ueshiba T Ichijo N Yamamoto, Annual report of the Health and Labour Science Research Grant 'Disorder of Adrenal Hormones' Research Committee, Japan 2003 117 119 (In Japanese)
26. Clinical study of adrenal incidentaloma in Korea. HY Kim SG Kim KW Lee JA Seo NH Kim KM Choi SH Baik DS Choi, Korean J Intern Med 2005 20 303 309 16491828
27. Pre-clinical Cushing's syndrome: an unexpected frequent cause of poor glycaemic control in obese diabetic patients. G Leibowitz A Tsur SD Chayen M Salameh I Raz E Cerasi DJ Gross, Clin Endocrinol (Oxf) 1996 44 717 722 10.1046/j.1365-2265.1996.737558.x 8759185
28. Occult Cushing's syndrome in type-2 diabetes. B Catargi V Rigalleau A Poussin N Ronci-Chaix V Bex V Vergnot H Gin P Roger A Tabarin, J Clin Endocrinol Metab 2003 88 5808 5813 10.1210/jc.2003-030254 14671173
29. Association of subclinical hypercortisolism with type 2 diabetes mellitus: a case-control study in hospitalized patients. I Chiodini M Torlontano A Scillitani M Arosio S Bacci S Di Lembo P Epaminonda G Augello R Enrini B Ambrosi G Adda V Trischitta, Eur J Endocrinol 2005 153 6 837 44 10.1530/eje.1.02045 16322389
30. The Diagnosis of Cushing's Syndrome: An Endocrine Society Clinical Practice Guideline. LK Nieman BM Biller JW Findling J Newell-Price MO Savage PM Stewart VM Montori, J Clin Endocrinol Metab 2008 93 1526 1540 10.1210/jc.2008-0125 18334580
31. Effect of experimental potassium deficiency on glucose and insulin metabolism. JW Rowe JD Tobin RM Rosa R Andres, Metabolism 1980 29 498 502 10.1016/0026-0495(80)90074-8 6991855
32. Insulin sensitivity in patients with primary aldosteronism: a follow-up study. C Catena R Lapenna S Baroselli E Nadalini GL Colussi M Novello G Favret A Melis A Cavarape LA Sechi, J Clin Endocrinol Metab 2006 91 3457 3463 10.1210/jc.2006-0736 16822818
33. Insulin resistance and hyperinsulinemia are related to plasma aldosterone levels in hypertensive patients. G Colussi C Catena R Lapenna E Nadalini A Chiuch LA Sechi, Diabetes Care 2007 30 2349 2354 10.2337/dc07-0525 17575088
34. Cortisol and the metabolic syndrome in South Asians. AM Ward CH Fall CE Stein K Kumaran SR Veena PJ Wood HE Syddall DI Phillips, Clin Endocrinol (Oxf) 2003 58 500 505 10.1046/j.1365-2265.2003.01750.x 12641634
35. Pancreatic -cells are important targets for the diabetogenic effects of glucocorticoids. F Delaunay A Khan A Cintra B Davani ZC Ling A Andersson CG Ostenson J Gustafsson S Efendic S Okret, J Clin Invest 1997 100 2094 2098 10.1172/JCI119743 9329975
36. A survey on adrenal incidentaloma in Italy. Study Group on Adrenal Tumors of the Italian Society of Endocrinology. F Mantero M Terzolo G Arnaldi G Osella AM Masini A Al M Giovagnetti G Opocher A Angeli, J Clin Endocrinol Metab 2000 85 637 644 10.1210/jc.85.2.637 10690869
37. Incidentally discovered adrenal tumors: an institutional perspective. MF Herrera CS Grant JA van Heerden PF Sheedy DM Ilstrup, Surgery 1991 110 1014 1021 1745970
38. Development of overt Cushing's syndrome in patients with adrenal incidentaloma. L Barzon F Fallo N Sonino M Boscaro, Eur J Endocrinol 2002 146 61 66 10.1530/eje.0.1460061 11751069
39. Preclinical Cushing's syndrome in adrenal "incidentalomas": comparison with adrenal Cushing's syndrome. M Reincke J Nieke GP Krestin W Saeger B Allolio W Winkelmann, J Clin Endocrinol Metab 1992 75 826 832 10.1210/jc.75.3.826 1517373